Menu Search
Equities

Formycon AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
FYB:STU

Formycon AG

Actions
  • Price (EUR)22.95
  • Today's Change0.300 / 1.32%
  • Shares traded0.00
  • 1 Year change-57.73%
  • Beta0.4779
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

  • Revenue in EUR (TTM)51.78m
  • Net income in EUR-169.77m
  • Incorporated2012
  • Employees245.00
  • Location
    Formycon AGFraunhoferstrasse 15, PlaneggMARTINSRIED 82152GermanyDEU
  • Phone+49 89 864667100
  • Fax+49 89 864667110
  • Websitehttps://www.formycon.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.